Kyprolis | search
Click here to view Kyprolis news from 60+ newspapers.
Bookmark or Share- Kyprolis: Side Effects, Uses, Dosage, and More - HealthlineAsk your doctor. Q&A. Drug Images. What is Kyprolis (carfilzomib)? If you’re looking at treatment options for a certain type of cancer, your doctor may prescribe Kyprolis for you. Kyprolis is...
- Relapsed multiple Myeloma Treatment | KYPROLIS® (carfilzomib)APPROVED USE. KYPROLIS. ®. (carfilzomib) is a prescription medication used to treat adult patients with relapsed or refractory multiple myeloma who have received one to three previous treatments for multiple myeloma.
- KYPROLIS® (carfilzomib) for Relapsed/Refractory Multiple MyelomaKYPROLIS ® is indicated as a single agent for the treatment of patients with relapsed or refractory multiple myeloma who have received one or more lines of therapy. Learn about KYPROLIS® and 4 combination treatments for relapsed/refractory multiple myeloma patients at first relapse. See Full Safety Info.
- Carfilzomib - WikipediaCarfilzomib, sold under the brand name Kyprolis, is an anti-cancer medication acting as a selective proteasome inhibitor. Chemically, it is a tetrapeptide epoxyketone and an analog of epoxomicin. It was developed by Onyx Pharmaceuticals. The US Food and Drug Administration (FDA) approved it in July 2012.
- What is KYPROLIS® (carfilzomib)?Learn more about how KYPROLIS® works as a proteasome inhibitor, and discover study data from four phase 3 clinical trials. See Full Safety Info.
More
